Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
- PMID: 33478649
- DOI: 10.1016/j.jacc.2020.11.036
Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain?
Keywords: LDL; cholesterol; coronary artery bypass; coronary disease; myocardial revascularization; percutaneous coronary intervention; prevention.
Conflict of interest statement
Author Disclosures Dr. Ohman has reported research grants from Abiomed and Cheisi USA; and has served as a consultant for Abiomed, Cara Therapeutics, Chiesi USA, Cytokinetics, Imbria Pharmaceuticals, Otsuka Pharmaceuticals, Milestone Pharmaceuticals, and XyloCor Therapeutics. Dr. Nanna has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
-
Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization.J Am Coll Cardiol. 2021 Jan 26;77(3):259-267. doi: 10.1016/j.jacc.2020.11.011. Epub 2020 Nov 13. J Am Coll Cardiol. 2021. PMID: 33197560 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
